Pharmacological Treatment of Insomnia
The complaint of trouble sleeping is very common in the practice of sleep medicine, and every physician who wants to be known as a sleep specialist should be knowledgeable about insomnia and have an organized and systematic approach to this problem. It has been estimated that 9% of adults in the United States have a complaint of insomnia, although the prevalance may be as high as 22%. Patients with insomnia view their problem in very emotional terms and for them it is very serious. And when patients see improvement, they are very grateful patients. Additionally, a complaint of insomnia increases morbidity in the elderly, for reasons ranging from falls to coronary events. Utilization of health care resources is higher in patients with severe insomnia. Insomnia should be considered a serious complaint from the patient because of the associated impairment of psychosocial function and quality of life. Insomnia can impair daytime alertness, concentration, memory, and ability to carry out daily tasks.
KeywordsChronic Obstructive Pulmonary Disease Sleep Medicine Chronic Insomnia Primary Insomnia Rebound Insomnia
Unable to display preview. Download preview PDF.
- 5.Krystal AD, Walsh JK, Laska E, et al. (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Eur Neuropsychopharmacol 14:793–799.Google Scholar
- 6.Ancoli-Israel S, Roth T (1999) Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 22:S347–S353.Google Scholar
- 10.Hobbs W, Rall T, Verdoon T. In: Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 9th ed. (Gilman AG, ed.) McGraw-Hill, New York, NY, 1996, pp. 361–396.Google Scholar
- 11.Hypnotic drugs. (2000) Med Lett 42:71–72.Google Scholar
- 16.Nicholson A Clinical pharmacology and therapeutics. In: Principles and Practice of Sleep Medicine. 2nd ed. (Kryger M, Roth T, Dement W, eds.) WB Saunders, Philadelphia, PA, 1994, pp. 355–363.Google Scholar
- 20.Lobo B, Greene W (1997) Zolpidem: distinct from triazolam? Clin Pharmacokinet 29:142–153.Google Scholar
- 43.Almeida Montes LG, Ontiveros Uribe MP, Cortes Sotres J, et al. (2003) Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci 28:191–196.Google Scholar